Mylan Completes $800 Million Private Placement

November 24, 2010

Cahill represented the initial purchasers in a Rule 144A/Reg S offering of $800,000,000 6% Senior Notes due 2018 for Mylan Inc., a leading generics and specialty pharmaceutical company. The proceeds were used to repay a portion of the Company's existing U.S. Tranche B Term Loans.